Stockscreener 앱 받기
3.11
2.81%
0.08
전일 마감가:
$3.03
열려 있는:
$3.07
하루 거래량:
310.06K
Relative Volume:
1.50
시가총액:
$74.72M
수익:
$48.20M
순이익/손실:
$-35.05M
주가수익비율:
-1.9843
EPS:
-1.5673
순현금흐름:
$-13.02M
1주 성능:
+39.06%
1개월 성능:
+76.99%
6개월 성능:
+34.85%
1년 성능:
+3.15%
1일 변동 폭
$2.96
$3.3911
1주일 범위
$2.01
$3.3911
52주 변동 폭
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
명칭
Celularity Inc
전화
(908) 768-2170
주소
170 PARK AVE, FLORHAM PARK
CELU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
3.12 | 53.65M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.21 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
546.99 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.99 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
565.60 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.33 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-30 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-06-22 | 개시 | H.C. Wainwright | Buy |
| 2022-04-06 | 다운그레이드 | Truist | Buy → Hold |
| 2022-01-28 | 개시 | Oppenheimer | Outperform |
| 2021-11-24 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Celularity Inc 주식(CELU)의 최신 뉴스
What analysts say about Celularity Inc. Equity Warrant stockBreakthrough profit margins - jammulinksnews.com
Is Celularity Inc. a good long term investmentPhenomenal returns - jammulinksnews.com
What drives Celularity Inc. stock priceMarket-leading capital gains - PrintWeekIndia
Celularity Inc. Equity Warrant Stock Analysis and ForecastOutstanding capital growth - Autocar Professional
What drives Celularity Inc. Equity Warrant stock priceRapid capital growth - Autocar Professional
Is Celularity Inc. Equity Warrant a good long term investmentJaw-dropping returns - jammulinksnews.com
What analysts say about Celularity Inc. stockRapid-fire capital growth - jammulinksnews.com
Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsCarefully Curated High Return Stocks - Newser
Celularity Stock Surges Over 8% Amid Florida Stem Cell Policy, New Partnership Boost - AInvest
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionInsider Strategy Insight - beatles.ru
Celularity Inc. Plunges 16.94% Amid Volatile Trading - AInvest
What makes Celularity Inc. stock price move sharplyRapid Gain Targets - Newser
Celularity Stock: Time to Reconsider? - StocksToTrade
Celularity Inc (CELU) Stock: A Year of Market Fluctuations - investchronicle.com
How Celularity Inc. Equity Warrant stock performs during market volatility3x Growth Potential - Newser
How Celularity Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
What makes Celularity Inc. Equity Warrant stock price move sharplyFree Access to Community with 300% Return - Newser
Why Celularity Inc. stock attracts strong analyst attentionFree Stock Tips Group - Newser
Celularity Inc. Surges Over 8% Pre-Market Amid Florida Stem Cell Policy, New Partnership Boost - 富途牛牛
Celularity Inc. Partners with Fountain Life to Provide Stem Cell Therapies Following New Florida Law - Nasdaq
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law - GlobeNewswire
Florida's New Stem Cell Law: Celularity and Fountain Life Team Up to Revolutionize Patient Care - Stock Titan
Celularity (NASDAQ:CELU) Trading Down 8.1% – Should You Sell? - Defense World
Celularity hails new Florida law opening patient access to stem cell therapies - TipRanks
Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies - The Manila Times
Two Sigma Investments LP Invests $93,000 in Celularity Inc. (NASDAQ:CELU) - Defense World
Celularity (NASDAQ:CELU) Shares Down 10.4% – Here’s Why - Defense World
# Celularity terminates CFO, appoints interim replacement By Investing.com - Investing.com South Africa
Celularity stock falls after CFO David Beers terminated By Investing.com - Investing.com Nigeria
Celularity stock falls after CFO David Beers terminated - Investing.com Australia
# Celularity terminates CFO, appoints interim replacement - Investing.com Australia
Celularity Inc (CELU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.03%
0.17%
자본화:
|
볼륨(24시간):